as on March 14, 2026 at 6:59 am IST
Day's Low
Day's High
6.32%
Downside
1.84%
Upside
52 Week's Low
52 Week's High
55.26%
Downside
38.95%
Upside
Check Kure Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$47.8M
EPS (TTM)
-4.56
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-207.36%
Compare market cap, revenue, PE, and other key metrics of Kure Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $47.8M | NA | NA | 0.00% | |
| BUY | $42.5B | 123.09% | 136.94 | 8.45% | |
| BUY | $125.1B | 123.08% | 32.16 | 32.94% | |
| NA | $34.5B | NA | 120.53 | 5.37% | |
| BUY | $81.9B | 58.36% | 18.69 | 31.41% |
The Kure Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Kure Therapeutics Inc investment value today
Current value as on today
₹88,561
Returns
Returns from Kure Therapeutics Inc Stock
Dollar Returns*
₹6,309 (+6.31%)
Search interest for Kure Therapeutics Inc Stock has increased by 18% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:18% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, OKUR stock has moved up by 15.4%
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 31.2% return, outperforming this stock by 55.0%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 71.6% return, outperforming this stock by 163.5%
| Organisation | Kure Therapeutics Inc |
| Headquarters | 6707 Winchester Circle, Boulder, CO, United States, 80301 |
| CEO | Dr. Nicholas A. Saccomano Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. James Blake Ph.D. | Senior Vice President of Computational Drug Discovery |
Dr. Kevin S. Litwiler Ph.D. | Senior Vice President of DMPK & Clinical Pharmacology |
Ms. Roberta Alton | Senior VP of Clinical Operations |
Dr. Nicholas A. Saccomano Ph.D. | President, CEO & Director |
Mr. Jason A. Leverone CPA | Chief Financial Officer |
Dr. Samuel Agresta M.D., M.P.H. | Chief Medical Officer |
Dr. Dylan Hartley Ph.D. | Chief Scientific Officer |
Mr. Rogan P. Nunn J.D. | General Counsel & Secretary |
Dr. Mark L. Boys Ph.D. | Senior Vice President of Discovery Chemistry |
Kure Therapeutics Inc share price today is $3.8 as on at the close of the market. Kure Therapeutics Inc share today touched a day high of $3.87 and a low of $3.56.
Kure Therapeutics Inc share touched a 52 week high of $5.28 on and a 52 week low of $1.7 on . Kure Therapeutics Inc stock price today i.e. is closed at $3.8,which is 28.03% down from its 52 week high and 123.53% up from its 52 week low.
Kure Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Kure Therapeutics Inc (OKUR) shares with as little as ₹92.409 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹924.09 in Kure Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Kure Therapeutics Inc share’s latest price of $3.8 as on March 14, 2026 at 1:29 am IST, you will get 2.6316 shares of Kure Therapeutics Inc. Learn more about
fractional shares .